How often and under which circumstances do Mexican pharmacy vendors recommend misoprostol to induce an abortion?

International Perspectives on Sexual and Reproductive Health

Volumn 37, Issue 2, 2011, Pages 75-83

  Lara, Diana ^a   García, Sandra G ^b   Wilson, Kate S ^b   Paz, Francisco ^a  

^a IBIS REPRODUCTIVE HEALTH   (United States)

^b Instituto Nacional de Neurología y Neurocirugía ^*

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; MISOPROSTOL;

ABORTION; ACCESSIBILITY; DRUG PRESCRIBING; HEALTH WORKER; MULTIVARIATE ANALYSIS; SOCIOECONOMIC STATUS; TRAINING; WOMENS HEALTH;

ADOLESCENT; ADULT; ARTICLE; CLINICAL COMPETENCE; FACTUAL DATABASE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INDUCED ABORTION; MALE; METHODOLOGY; MEXICO; MULTIVARIATE ANALYSIS; PHARMACIST; PHARMACY; PREGNANCY; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS; STATISTICS;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MEXICO; MISOPROSTOL; MULTIVARIATE ANALYSIS; PHARMACIES; PHARMACISTS; PREGNANCY; SOCIOECONOMIC FACTORS; YOUNG ADULT;

FEDERAL DISTRICT [MEXICO]; MEXICO [NORTH AMERICA]; MEXICO CITY;

EID: 80051992329     PISSN: 19440391     EISSN: None     Source Type: Journal    
DOI: 10.1363/3707511     Document Type: Article

References (19)

1. Bracken H, Providing Medical Abortion in Developing Countries: An Introductory Guidebook, second ed., New York: Gynuity Health Projects, 2009.
2. von Hertzen H et al., Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomized controlled equivalence trial, Lancet, 2007, 369(9577):1938-1946.
3. Moreno-Ruiz NL et al., Alternatives to mifepristone for early medical abortion, International Journal of Gynaecology & Obstetrics, 2007, 96(3):212-218.
4. Sherris J et al., Misoprostol use in developing countries: results from a multicountry study, International Journal of Gynaecology & Obstetrics, 2005, 88(1):76-81.
5. Mexico City, Cámara de Diputados del H. Congreso de la Unión, art. 226, June 2, 2004.
6. Huntington D and Schuler SR, The simulated client method: evaluating client-provider interactions in family planning clinics, Studies in Family Planning, 1993, 24(3):187-193.
7. Madden JM et al., Undercover careseekers: simulated clients in the study of health provider behavior in developing countries, Social Science & Medicine, 1997, 45(10):1465-1482.
8. Lara D et al., Pharmacy provision of medical abortifacients in a Latin American city, Contraception, 2006, 74(5):394-399.
9. Miller S et al., Misoprostol and declining abortion-related morbidity in Santo Domingo, Dominican Republic: a temporal association, BJOG, 2005, 112(9):1291-1296.
10. Billlings DL et al., Pharmacy worker practices related to use of misoprostol for abortion in one Mexican state, Contraception, 2009, 79(6):445-451.
11. Distrito Federal, Decreto por el que se reforma el Código Penal para el Distrito Federal y se adiciona la Ley de Salud para el Distrito Federal, 2007, art. 1, Órgano de Gobierno del Distrito Federal, No. 70, April 26, 2007.
12. Consejo Nacional de Población (CONAPO), Índices de Marginación, 2000, Mexico City: CONAPO, 2000.
13. Juarez F et al., Addressing Adolescent Women's Sexual and Reproductive Health Needs in Mexico: Challenges and Opportunities, New York: Guttmacher Institute, 2010, http://www.guttmacher.org/pubs/Adolescentes-Mexico.pdf, accessed Feb. 23, 2011 (in Spanish).
14. Pick S et al., Pharmacists and market herb vendors: abortifacient providers in Mexico City, in: Mundigo AI and Indriso C, eds., Abortion in the Developing World, London: Zed Books, 1999, pp. 293-310.
15. Gould H, Ellertson C and Corona G, Knowledge and attitudes about the differences between emergency contraception and medical abortion among middle-class women and men of reproductive age in Mexico City, Contraception, 2002, 66(6):417-426.
16. Alte D, Weitschies W and Ritter CA, Evaluation of consultation in community pharmacies with mystery shoppers, Annals of Pharmacotherapy, 2007, 41(6):1023-1030.
17. Goel PK et al., Influence of location and staff knowledge on quality of retail pharmacy prescribing for childhood diarrhea in Kenya, International Journal for Quality in Health Care, 1996, 8(6):519-526.
18. Fiala C et al., The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation, Human Reproduction, 2005, 20(11):3072-3077.
19. Costa SH, Commercial availability of misoprostol and induced abortion in Brazil, International Journal of Gynaecology & Obstetrics, 1998, 63(Suppl. 1):S131-S139.